Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Catalyst Pharm Inc
(NQ:
CPRX
)
21.46
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
681
Open
21.46
Bid (Size)
21.25 (1)
Ask (Size)
21.90 (5)
Prev. Close
21.46
Today's Range
21.46 - 21.46
52wk Range
11.89 - 21.93
Shares Outstanding
102,780,151
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Catalyst Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 6, 2024
October 22, 2024
The Company will Host a Conference Call and Webcast on Thursday, November 7, 2024, at 8:30 AM ET
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Amphastar Casts Wide Net, Hauls In Profits, Gets Rating Upgrade
October 15, 2024
Amphastar hit an all-time high in August 2023 and consolidated. It could be forming the right side of a cup base that started in January.
Via
Investor's Business Daily
Performance
YTD
+25.42%
+25.42%
1 Month
+9.71%
+9.71%
3 Month
+22.77%
+22.77%
6 Month
+40.91%
+40.91%
1 Year
+75.90%
+75.90%
More News
Read More
NASDAQ:CPRX—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
October 14, 2024
Via
Chartmill
Alkermes Stock Jumps Nearly 30% In 3 Months Amid Hefty Profits
October 14, 2024
Via
Investor's Business Daily
NASDAQ:CPRX is showing good growth, while it is not too expensive.
September 13, 2024
Via
Chartmill
Exploring the Growth Potential of NASDAQ:CPRX as It Nears a Breakout.
August 29, 2024
Via
Chartmill
The Latest Analyst Ratings For Catalyst Pharmaceuticals
August 12, 2024
Via
Benzinga
Looking for growth without the hefty price tag? Consider NASDAQ:CPRX.
October 09, 2024
Via
Chartmill
Catalyst Pharmaceuticals Donates $100,000 to the American Red Cross Hurricane Helene Relief Efforts
October 08, 2024
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024
October 01, 2024
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Received Approval to Commercialize FIRDAPSE® in Japan
September 24, 2024
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
A Biotech Breakout Will Be Led By Small Caps
September 23, 2024
Via
Talk Markets
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Interest Rates
Why NASDAQ:CPRX Is a Standout High-Growth Stock in a Consolidation Phase.
September 19, 2024
Via
Chartmill
Keros Therapeutics Stock Meets 80-Plus RS Rating Benchmark
September 05, 2024
Via
Investor's Business Daily
Innovative Drugmaker Roivant Puts Up Really Healthy Sales Numbers
August 29, 2024
Via
Investor's Business Daily
Biohaven Stock Earns Relative Strength Rating Upgrade
August 21, 2024
Via
Investor's Business Daily
SpringWorks Therapeutics Stock Clears Key Benchmark, Hitting 80-Plus RS Rating
August 21, 2024
Via
Investor's Business Daily
Investors should take notice of NASDAQ:CPRX—it offers a great deal for the fundamentals it presents.
August 21, 2024
Via
Chartmill
NASDAQ:CPRX stands out as a growth opportunity that won't break the bank.
August 21, 2024
Via
Chartmill
Immunome Stock Sees RS Rating Jump To 91
August 20, 2024
Via
Investor's Business Daily
Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences
August 20, 2024
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
PTC Therapeutics Stock Earns RS Rating Upgrade To 83
August 19, 2024
Via
Investor's Business Daily
Top 3 Health Care Stocks That May Crash In August
August 14, 2024
Via
Benzinga
CPRX Stock Earnings: Catalyst Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024
August 07, 2024
Via
InvestorPlace
Catalyst Pharmaceuticals Reports Strong Second Quarter 2024 Financial Results and Provides Corporate Update
August 07, 2024
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.